Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1983 1
1985 1
1986 2
1987 2
1988 3
1989 7
1990 7
1991 6
1992 2
1993 3
1994 8
1995 1
1996 3
1997 1
1998 2
1999 1
2000 3
2001 6
2002 2
2003 8
2004 5
2005 4
2006 7
2007 2
2008 4
2009 4
2010 5
2011 8
2012 6
2013 3
2014 9
2015 4
2016 8
2017 12
2018 10
2019 4
2020 5
2021 10
2022 5
2023 6
2024 6
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Amyloidosis in Alzheimer's disease.
Allsop D, Williams CH. Allsop D, et al. Biochem Soc Trans. 1994 Feb;22(1):171-5. doi: 10.1042/bst0220171. Biochem Soc Trans. 1994. PMID: 8206218 Review. No abstract available.
Presenilins--in search of functionality.
Karran EH, Allsop D, Christie G, Davis J, Gray C, Mansfield F, Ward RV. Karran EH, et al. Among authors: allsop d. Biochem Soc Trans. 1998 Aug;26(3):491-6. doi: 10.1042/bst0260491. Biochem Soc Trans. 1998. PMID: 9765902 Review.
Fibrillogenesis of beta-amyloid.
Allsop D, Howlett D, Christie G, Karran E. Allsop D, et al. Biochem Soc Trans. 1998 Aug;26(3):459-63. doi: 10.1042/bst0260459. Biochem Soc Trans. 1998. PMID: 9765896 Review. No abstract available.
Inflammatory mechanisms in Alzheimer's disease.
Eikelenboom P, Zhan SS, van Gool WA, Allsop D. Eikelenboom P, et al. Among authors: allsop d. Trends Pharmacol Sci. 1994 Dec;15(12):447-50. doi: 10.1016/0165-6147(94)90057-4. Trends Pharmacol Sci. 1994. PMID: 7886816 Review.
A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies.
Aggidis A, Devitt G, Zhang Y, Chatterjee S, Townsend D, Fullwood NJ, Ortega ER, Tarutani A, Hasegawa M, Cooper A, Williamson P, Mendoza-Oliva A, Diamond MI, Mudher A, Allsop D. Aggidis A, et al. Among authors: allsop d. Alzheimers Dement. 2024 Nov;20(11):7788-7804. doi: 10.1002/alz.14246. Epub 2024 Oct 3. Alzheimers Dement. 2024. PMID: 39360630 Free PMC article.
Alpha-synuclein and the pathogenesis of Parkinson's disease.
Martin FL, Williamson SJ, Paleologou KE, Allsop D, El-Agnaf OM. Martin FL, et al. Among authors: allsop d. Protein Pept Lett. 2004 Jun;11(3):229-37. doi: 10.2174/0929866043407138. Protein Pept Lett. 2004. PMID: 15182224 Review.
186 results